Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-25-000063
Filing Date
2025-05-12
Accepted
2025-05-12 16:05:27
Documents
1
Period of Report
2025-05-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 6858
  Complete submission text file 0001735276-25-000063.txt   8423
Mailing Address C/O ALLERGAN 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
PYOTT DAVID E I (Reporting) CIK: 0001051578 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 25934712

Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)